Skip to main content
Equibles

GUGGENHEIM CAPITAL LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1283072 Chicago, IL
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,835,897
-$444,012 QoQ
Shares Held
39,318
+5.9% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#171
of 786 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GUGGENHEIM CAPITAL LLC holds $211,944,812 across 76 Biotechnology names. ALNY ranks #3 (5.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 115,233 $57,239,687
2 REGN
Regeneron Pharmaceuticals, Inc.
 45,969 $28,663,508
3 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		39,318 $11,835,897
4 INCY
Incyte Corp
 57,780 $6,549,940
5 RVMD
Revolution Medicines, Inc.
 26,474 $4,958,050
6 INSM
INSMED Inc
 38,766 $4,133,230
7 MRNA
Moderna, Inc.
 55,313 $3,873,568
8 BMRN
Biomarin Pharmaceutical Inc
 66,874 $3,826,530

All Filings in ALNY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,835,897 39,318
2026-03-31 $12,279,909 37,114
2025-12-31 $15,959,682 40,135
2025-09-30 $3,933,000 8,625
2025-06-30 $3,472,532 10,649
2025-03-31 $3,339,337 12,367
2024-12-31 $3,007,967 12,783
2024-09-30 $4,193,656 15,248
2024-06-30 $4,662,441 19,187
2024-03-31 $3,162,660 21,162
2023-12-31 $3,397,718 17,751
2023-09-30 $3,053,912 17,244
2023-06-30 $3,735,359 19,666
2023-03-31 $4,003,594 19,986
2022-12-31 $4,947,159 20,817
2022-09-30 $3,854,480 19,257
2022-06-30 $3,697,151 25,349
2022-03-31 $4,203,737 25,744
2021-12-31 $4,460,801 26,305
2021-09-30 $4,501,985 23,844
2021-06-30 $4,396,840 25,937
2021-03-31 $4,156,351 29,438
2020-12-31 $4,112,640 31,643
2020-09-30 $5,539,206 38,044
2020-06-30 $6,686,870 45,148
2020-03-31 $4,551,889 41,818